 Supporting Member (50+ posts)
Joined: Feb 2013 Posts: 78 | I read in a recent paper that the KRAS mutation is only present in 5% of head and neck cancers, which is why there is no genetic testing like in corectal cancer. I was treated at MSKCC and was not offered/recommended Erbitux as a sole chemo agent.
Andrew
age 25
early 10/12 - enlarged lymph node area
01/13 SCC of L tonsil, L BOT, 2 L lymph nodes
stage IVa, T2N2bM0, HPV+
2/13 2 doses cisplatin big bag, 2 doses weekly cisplatin + 35x IMRT
4/13 TX finished
7/13 PET/CT - NED!
| 
